Luxuly Abraham

FDA investigator

Appears on 7 documents from 2023 to 2026, most often at sites in New Jersey. Most often cites design and construction features (21 CFR 211.42).

7
Documents on file
3.6
Observations per 483
2023
First seen
2026
Most recent

What they cite most

From 22 observations

Activity by year

2023: 1, 2024: 2, 2025: 3, 2026: 1

Where

New Jersey 2 · New York 2 · Pennsylvania 1 · South Carolina 1

Is Luxuly Abraham coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Linde Gas & Equipment Inc.Apr 1, 2026
483 Evaric Pharmaceuticals IncMay 16, 2025 · Hauppauge, New York
483 ENGLEWOOD LAB, INC.Apr 23, 2025 · TOTOWA, New Jersey
483 Bausch & Lomb IncorporatedFeb 27, 2025 · Greenville, South Carolina
483 Apothecus Pharmaceutical Corp.Nov 15, 2024 · HICKSVILLE, New York
483 Hikma Injectables USA Inc.Jun 25, 2024 · Dayton, New Jersey
483 Linde IncMar 26, 2023 · Pennsylvania

About this profile

What does Luxuly Abraham inspect?

Luxuly Abraham appears on 7 documents on file covering 7 sites, most often in New Jersey.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.67(a) and 21 CFR 211.100(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Luxuly Abraham is dated Apr 1, 2026.